Friday, 18 October 2019

Beckman Coulter Life Sciences acquires Cytobank

06 June 2019 | News

Cytobank provides an industry-leading, cloud and machine learning-based software platform for multi-parametric single-cell data analysis

image credit- technologynetworks.com

image credit- technologynetworks.com

Beckman Coulter Life Sciences has announced its acquisition of Cytobank, a privately held, single cell data analysis, software as a service (SaaS) company based in Santa Clara, California.

Cytobank provides an industry-leading, cloud and machine learning-based software platform for multi-parametric single-cell data analysis, sharing and archiving. The platform accelerates research productivity by enabling efficient high-dimensional multi-omics data analysis, visualization and collaboration across multiple sites.

The technology pairs naturally with Beckman Coulter Life Sciences' CytoFLEX LX 21-color flow cytometer to meet the growing high-complexity workflow and data analysis needs of basic and clinical research scientists.

Cytobank will transition into Beckman Coulter Life Sciences under the Danaher Life Sciences platform, which generated approximately $6.5 billion in revenue during 2018. 

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account